Literature DB >> 20812023

GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.

Petra Popovics1, Alan J Stewart.   

Abstract

GPR39 is a vertebrate G protein-coupled receptor related to the ghrelin/neurotensin receptor subfamily. The receptor is expressed in a range of tissues including the pancreas, gut/gastrointestinal tract, liver, kidney and in some regions of the brain. GPR39 was initially thought to be the cognitive receptor for the peptide hormone, obestatin. However, subsequent in vitro studies have failed to demonstrate binding of this peptide to the receptor. Zn(2+) has been shown to be a potent stimulator of GPR39 activity via the Gα(q), Gα(12/13) and Gα(s) pathways. The potency and specificity of Zn(2+) in activating GPR39 suggest it to be a physiologically important agonist. GPR39 is now emerging as an important transducer of autocrine and paracrine Zn(2+) signals, impacting upon cellular processes such as insulin secretion, gastric emptying, neurotransmission and epithelial repair. This review focuses on the molecular, structural and biological properties of GPR39 and its various physiological functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812023     DOI: 10.1007/s00018-010-0517-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  69 in total

1.  Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.

Authors:  Frédéric Tremblay; Ann-Marie T Richard; Sarah Will; Jameel Syed; Nancy Stedman; Mylène Perreault; Ruth E Gimeno
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

2.  Differential expression and functional characterization of luteinizing hormone receptor splice variants in human luteal cells: implications for luteolysis.

Authors:  Rachel E Dickinson; Alan J Stewart; Michelle Myers; Robert P Millar; W Colin Duncan
Journal:  Endocrinology       Date:  2009-02-26       Impact factor: 4.736

3.  Zinc and wound healing. Effects of zinc deficiency and zinc supplementation.

Authors:  H H Sandstead; V C Lanier; G H Shephard; D D Gillespie
Journal:  Am J Clin Nutr       Date:  1970-05       Impact factor: 7.045

4.  Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.

Authors:  Benjamin Dekel; Sally Metsuyanim; Kai M Schmidt-Ott; Edi Fridman; Jasmin Jacob-Hirsch; Amos Simon; Jehonathan Pinthus; Yoram Mor; Jonathan Barasch; Ninette Amariglio; Yair Reisner; Naftali Kaminski; Gideon Rechavi
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

6.  Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse.

Authors:  Dieder Moechars; Inge Depoortere; Benoit Moreaux; Betty de Smet; Ilse Goris; Luc Hoskens; Guy Daneels; Stefan Kass; Luc Ver Donck; Theo Peeters; Bernard Coulie
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

7.  Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors.

Authors:  K K McKee; C P Tan; O C Palyha; J Liu; S D Feighner; D L Hreniuk; R G Smith; A D Howard; L H Van der Ploeg
Journal:  Genomics       Date:  1997-12-15       Impact factor: 5.736

8.  Seizures and neuronal damage in mice lacking vesicular zinc.

Authors:  T B Cole; C A Robbins; H J Wenzel; P A Schwartzkroin; R D Palmiter
Journal:  Epilepsy Res       Date:  2000-04       Impact factor: 3.045

9.  Molecular characterization of sequence and expression of chicken GPR39.

Authors:  Ichiro Yamamoto; Makoto Numao; Yuka Sakaguchi; Nobumichi Tsushima; Minoru Tanaka
Journal:  Gen Comp Endocrinol       Date:  2006-12-16       Impact factor: 2.822

10.  Ghrelin and obestatin: different role in fetal lung development?

Authors:  Susana Nunes; Cristina Nogueira-Silva; Emanuel Dias; Rute S Moura; Jorge Correia-Pinto
Journal:  Peptides       Date:  2008-08-26       Impact factor: 3.750

View more
  41 in total

1.  Extracellular pH regulates zinc signaling via an Asp residue of the zinc-sensing receptor (ZnR/GPR39).

Authors:  Limor Cohen; Hila Asraf; Israel Sekler; Michal Hershfinkel
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

2.  Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.

Authors:  Stefan Peukert; Richard Hughes; Jill Nunez; Guo He; Zhao Yan; Rishi Jain; Luis Llamas; Sarah Luchansky; Adam Carlson; Guiqing Liang; Vidya Kunjathoor; Mike Pietropaolo; Jeffrey Shapiro; Anja Castellana; Xiaoping Wu; Avirup Bose
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

3.  ZIGIR, a Granule-Specific Zn2+ Indicator, Reveals Human Islet α Cell Heterogeneity.

Authors:  Ebrahim H Ghazvini Zadeh; ZhiJiang Huang; Jing Xia; Daliang Li; Howard W Davidson; Wen-Hong Li
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

4.  Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.

Authors:  Seiji Sato; Xi-Ping Huang; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2016-10-17       Impact factor: 4.436

5.  Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1.

Authors:  Casey E Romanoski; Nam Che; Fen Yin; Nguyen Mai; Delila Pouldar; Mete Civelek; Calvin Pan; Sangderk Lee; Ladan Vakili; Wen-Pin Yang; Paul Kayne; Imran N Mungrue; Jesus A Araujo; Judith A Berliner; Aldons J Lusis
Journal:  Circ Res       Date:  2011-07-07       Impact factor: 17.367

6.  Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Authors:  Frederic Bassilana; Adam Carlson; Jennifer A DaSilva; Bianka Grosshans; Solange Vidal; Valerie Beck; Barbara Wilmeringwetter; Luis A Llamas; Todd B Showalter; Pascal Rigollier; Aaron Bourret; Arun Ramamurthy; Xu Wu; Fred Harbinski; Samantha Plonsky; Lac Lee; Heinz Ruffner; Paola Grandi; Markus Schirle; Jeremy Jenkins; Andreas W Sailer; Tewis Bouwmeester; Jeffrey A Porter; Vic Myer; Peter M Finan; John A Tallarico; Joseph F Kelleher; Klaus Seuwen; Rishi K Jain; Sarah J Luchansky
Journal:  Nat Chem Biol       Date:  2014-03-16       Impact factor: 15.040

7.  Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.

Authors:  Markus Boehm; David Hepworth; Paula M Loria; Lisa D Norquay; Kevin J Filipski; Janice E Chin; Kimberly O Cameron; Martin Brenner; Peter Bonnette; Shawn Cabral; Edward Conn; David C Ebner; Denise Gautreau; John Hadcock; Esther C Y Lee; Alan M Mathiowetz; Michelle Morin; Lucy Rogers; Aaron Smith; Maria VanVolkenburg; Philip A Carpino
Journal:  ACS Med Chem Lett       Date:  2013-09-16       Impact factor: 4.345

8.  The Zn2+-sensing receptor, ZnR/GPR39, upregulates colonocytic Cl- absorption, via basolateral KCC1, and reduces fluid loss.

Authors:  Laxmi Sunuwar; Hila Asraf; Mark Donowitz; Israel Sekler; Michal Hershfinkel
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-16       Impact factor: 5.187

9.  Zinc Is Involved in Depression by Modulating G Protein-Coupled Receptor Heterodimerization.

Authors:  Mercè Tena-Campos; Eva Ramon; Cecylia S Lupala; Juan J Pérez; Karl-W Koch; Pere Garriga
Journal:  Mol Neurobiol       Date:  2015-04-09       Impact factor: 5.590

Review 10.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Authors:  Anthony P Davenport; Stephen P H Alexander; Joanna L Sharman; Adam J Pawson; Helen E Benson; Amy E Monaghan; Wen Chiy Liew; Chidochangu P Mpamhanga; Tom I Bonner; Richard R Neubig; Jean Philippe Pin; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.